Halozyme Therapeutics, Inc. (HALO)

67.82 +0.74 (+1.10%) USD  |  NASDAQ  |  Apr 10, 16:00
68.14 +0.32 (+0.47%) After-Hours: 20:00
More

Halozyme Therapeutics EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS LT Growth Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Johnson & Johnson Upgrade
Eli Lilly & Co. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Glaukos Corp. Upgrade
Agenus, Inc. --